Legal Representation
Attorney
Margaret C. McHugh
USPTO Deadlines
Next Deadline
20 days remaining
Non-Final Action E-Mailed
Due Date
January 21, 2026
Extension Available
Until April 21, 2026
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 23, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 23, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 23, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 21, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 21, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 21, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 21, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 8, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 2, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 2, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical preparations for use in the manufacture of pharmaceuticals
Class 005
Pharmaceuticals and preparations for health care, namely, oral therapeutics for the treatment of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS), fibromyalgia, exertional intolerance and post-exertional malaise; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment or prevention of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS), fibromyalgia, exertional intolerance and post-exertional malaise and associated mitochondrial and vascular dysfunction
Classification
International Classes
001
005